Pharmaceutical Approval Update.

Pharmaceutical Approval Update. P T. 2019 Sep;44(9):527-529 Authors: Choy M Abstract Alpelisib (Piqray) for HR-positive/HER2-negative, PIK3CA-mutated, advanced/ metastatic breast cancer; polatuzumab vedotin-piiq (Polivy) for diffuse large B-cell lymphoma; and eculizumab (Soliris) for neuromyelitis optica spectrum disorder. PMID: 31485143 [PubMed]
Source: P and T - Category: Drugs & Pharmacology Tags: P T Source Type: research